Oct 1, 2021 For Immediate Release – Fibrocor Therapeutics Inc, a precision medicine company developing first in class drugs for IPF and other fibrotic diseases, is participating at the upcoming Piper Sandler Lung Day conference on October 15, 2021 at 11:30 am ET. The format will be a fireside discussion amongst investors, analysts and KOLs in the field regarding the progression of new medicines for the treatment of pulmonary diseases.
MEDIA RELATIONS
Julie A. Fotheringham
Partner, HAGEMAN Communications
[email protected]
416.951.7988